Child and adolescent suicides in Virginia: 1987 to 2003

Journal of Child and Adolescent Psychopharmacology

Volumn 15, Issue 4, 2005, Pages 655-663

  Vieweg, W Victor R ^a,c   Linker, Julie A ^a   Anum, Emmanuel A ^a   Turf, Elizabeth ^a   Pandurangi, Anand K ^a   Sood, Bela ^a   Fierro, Marcella F ^a,b   Fernandez, Antony ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Department of General Services   (United States)

^c NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACEBUTOLOL; AMITRIPTYLINE; CARBON MONOXIDE; CARISOPRODOL; CHLORPHENIRAMINE; COCAINE; CODEINE; COLCHICINE; CYCLOBENZAPRINE; DIPHENHYDRAMINE; DOXEPIN; DOXYLAMINE; ETHYLENE GLYCOL; FLUOXETINE; FLUVOXAMINE; HYDROXYZINE; IBUPROFEN; IMIPRAMINE; METHADONE; NORTRIPTYLINE; OXYCODONE; PARACETAMOL; PROPRANOLOL; QUETIAPINE; SALICYLIC ACID DERIVATIVE; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT; VERAPAMIL;

ADOLESCENT; AGE; CAUSE OF DEATH; CHILD PSYCHIATRY; DRUG INTOXICATION; EUROPEAN AMERICAN; FIREARM; GENDER; HANGING; HUMAN; INTOXICATION; MEDICAL RECORD; REVIEW; RISK FACTOR; SEX DIFFERENCE; SUICIDAL BEHAVIOR; SUICIDE; UNITED STATES;

ADOLESCENT; AFRICAN AMERICANS; AGE FACTORS; ANTIDEPRESSIVE AGENTS, TRICYCLIC; CHILD; ETHNIC GROUPS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GUIDELINES; HISPANIC AMERICANS; HUMANS; MALE; POISONING; RETROSPECTIVE STUDIES; SEX FACTORS; SUICIDE; VIRGINIA;

EID: 26444452112     PISSN: 10445463     EISSN: None     Source Type: Journal    
DOI: 10.1089/cap.2005.15.655     Document Type: Review

References (14)

1. FDA Public Health Advisory (October 27, 2003): Reports of suicidality in pediatric patients being treated with antidepressant medications for Major Depressive Disorder (MDD). U.S. Food and Drug Administration, 2003. www.fda.gov. Last accessed August 21, 2005.
2. FDA Talk Paper (October 27, 2003): Reports of suicidality in pediatric patients being treated with antidepressant medications for major depressive disorder (MDD). U.S. Food and Drug Administration, 2003. www.fda.gov. Last accessed August 21, 2005.
3. Holden C: PDA weighs suicide risk in children on antidepressants. Science 303:745, 2004.
4. Holinger PC, Offer D, Barter JT, Bell CC: Suicide and homicide among adolescents. New York, Guilford Press, 1994.
5. Microsoft Corporation: Microsoft Office Professional Edition 2003. Redmond, (WA): Microsoft Corporation, 2003.
6. MMWR: Methods of suicide among persons aged 10-19 years - United States, 1992-2001. MMWR Weekly 53:471-474, 2004.
7. National Center for Health Statistics: Population data for Virginia. National Center for Health Statistics, 2004. www.cdc.gov/nchs. Last accessed August 21, 2005.
8. National Library of Medicine: PubMed, 2004.
9. Spirito A, Overholser JC: Evaluating and treating adolescent suicide attempters: From research to practice. New York, Academic Press, 2003.
10. SPSS Inc.: SPSS for Windows, Version 12.0. Chicago, SPSS Inc., 2003.
11. U.S. Census Bureau: Population data for Virginia. U.S. Census Bureau, 2004. www.census.gov. Last accessed August 21, 2005.
12. U.S. Food and Drug Administration: FDA launches a multi-pronged strategy to strengthen safeguards for children treated with antidepressant medications. U.S. Food and Drug Administration, 2004a. www.fda.gov/bbs/topics/news/2004/ NEW0112 4.html. Last accessed August 21, 2005.
13. U.S. Food and Drug Administration: FDA proposed medication guidelines: About using antidepressants in children or teenagers. U.S. Food and Drug Administration, 2004b. www.fda.gov/cder/drug/antidepressants/SSRIMedication Guide.htm. Last accessed August 21, 2005.
14. Whittington CJ, Kendall T, Fonagy P, Cottrell D, Cotgrove A, Boddington E: Selective serotonin reuptake inhibitors in childhood depression: Systematic review of published versus unpublished data. Lancet 363:1341-1345, 2004.